Supplementary Table S3 from Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study [PDF]
Funda Meric-Bernstam +11 more
openalex +1 more source
Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program [PDF]
Noah Z. Feit +6 more
openalex +1 more source
Fast‐Responding O2 Gas Sensor Based on Luminescent Europium Metal‐Organic Frameworks (MOF‐76)
Luminescent MOF‐76 materials based on Eu(III) and mixed Eu(III)/Y(III) show rapid and reversible changes in emission intensity in response to O2 with very short response times. The effect is based on triplet quenching of the linker ligands that act as photosensitizers. Average emission lifetimes of a few milliseconds turn out to be mostly unaffected by
Zhenyu Zhao +5 more
wiley +1 more source
Research and practice on key drug safety monitoring under the normalization of centralized procurement: A case study of 13 selected drugs in a Province. [PDF]
Ding G, Ding J.
europepmc +1 more source
Tiotropium for the treatment of asthma: a drug safety evaluation [PDF]
Huib A.M. Kerstjens, Paul M. O’Byrne
openalex +1 more source
Bloodstream infections (BSI) are one of the leading causes of mortality and morbidity in both civilian and military populations. This paper summarizes recent progress in novel treatment strategies to manage BSI arising from both bacterial and fungal pathogens using molecules, particles, and materials to elicit host‐directed immunity.
Thomas Thomou +11 more
wiley +1 more source
Leveraging Large Language Models in Extracting Drug Safety Information from Prescription Drug Labels. [PDF]
Gisladottir U +6 more
europepmc +1 more source
Drug delegation and patient safety in municipal healthcare : A qualitative interview study
Locklindh, Sylvia, Jonsson, Karolina
openalex +1 more source
Self‐Immolative Activatable Nanoassembly toward Immuno‐Photodynamic Therapy in TME
A quinone methide‐gated, self‐immolative, H2O2‐responsive nano‐photosensitizer (Pyz/PS) is developed for targeted immuno‐photodynamic therapy. Pyz/PS selectively activates within tumor microenvironments, restores photosensitizer activity, generates ROS, and depletes intracellular GSH, enhancing oxidative stress.
Jing Li +10 more
wiley +1 more source

